Where network biology meets AI

Sygnomics SPOT-AI is a personalized oncology platform that unifies diagnostics, treatment, and therapeutics, creating better outcomes for patients.

Better patient stratification for Pharma:

  • Rescue clinical trials

  • Accelerate drug development

 

Clinical insight into patient disease network:

  • More accurate risk prediction

  • Advanced therapy matching

Introducing AI-powered Sygnomics Personalized Oncology Therapeutics (SPOT-AI)

Predictive biotechnology unlocks personalized oncology treatments using network maps and explainable AI to improve treatments at any disease stage.

Cancer is the 2nd leading cause of death in the U.S.

Big

600K/deaths a year

Expensive

$200B expenditure

Difficult

No two cancer patients are alike

Limited

10% therapeutic success rate

SPOT-AI helps improve patient outcomes by delivering more effective, personalized therapies through our proprietary Sygnomics Analytics Test (SAT).

More accurate risk prediction

Through the power of AI, oncologists can better understand the unique disease-driving characteristics of each individual patient

Better therapy matching

Our Sygnomics Analytics Test (SAT) accurately identifies the most effective therapies for each individual patient

The ability to rescue Clinical trials and accelerate drug development

SATs can serve as companion diagnostics to help pharma companies speed up trials and time-to-market, rescue failed trials, and get existing drugs approved for new indications

Help shape the future of personalized oncology

Interested in how you can improve the lives of cancer patients and their families? Reach out to learn about investment, collaboration, and employment opportunities.